徐金

2026

2014—2024年无锡市新发职业病流行病学特征分析

《中国工业医学杂志》

DOI

2026

2024年无锡市第二产业劳动者职业紧张及其影响因素分析

《中国健康教育》

2026

Abstract CT146: Sequential treatment with surufatinib combined with gemcitabine and nab-paclitaxel (AG) or AG alone as first-line therapy for locally advanced or metastatic pancreatic ductal adenocarcinoma (mPDAC) after 6 weeks of AG induction therapy: A two-cohort, exploratory phase II study

Cancer Research

DOI

2026

Organ-preserving surgery for solid pseudopapillary neoplasm of the pancreas: A multicentric study.

European Journal of Cancer

DOI

2024

第二产业职业人群睡眠质量在职业紧张与抑郁症状间中介效应分析

《中国职业医学》

2024

Pirfenidone alleviates fibrosis by acting on tumour–stroma interplay in pancreatic cancer

British Journal of Cancer

DOI

2024

CPT1B maintains redox homeostasis and inhibits ferroptosis to induce gemcitabine resistance via the KEAP1/NRF2 axis in pancreatic cancer.

Surgery

DOI

2023

Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity and chemo-response

Cell Reports Medicine

DOI

2023

Mitochondria-Related Transcriptome Characterization Associated with the Immune Microenvironment, Therapeutic Response and Survival Prediction in Pancreatic Cancer

International Journal of Molecular Sciences

DOI

2023

Anatomical features and technical difficulties in laparoscopic pancreaticoduodenectomy with various superior mesenteric artery-first approaches.

Hepatobiliary & Pancreatic Diseases International

DOI

2023

Histone acetylation insulator SET orchestrates PP2A inhibition and super-enhancer activation

bioRxiv

DOI

2023

Reappraisal of Tumor Deposit as a Prognostic Factor in Pancreatic Cancer

Annals of Surgical Oncology

DOI

2023

Metabolic reprogramming of cancer-associated fibroblasts in pancreatic cancer contributes to the intratumor heterogeneity of PET-CT

Computational and Structural Biotechnology Journal

DOI

2023

Cuproptosis-Related Gene DLAT as a Novel Biomarker Correlated with Prognosis, Chemoresistance, and Immune Infiltration in Pancreatic Adenocarcinoma: A Preliminary Study Based on Bioinformatics Analysis

Current Oncology

DOI

2023

CRIP1 fosters MDSC trafficking and resets tumour microenvironment via facilitating NF-κB/p65 nuclear translocation in pancreatic ductal adenocarcinoma

Gut

DOI

2023

Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets

Signal Transduction and Targeted Therapy

DOI

2023

Mechanical Regulation of Redox Balance via the Induction of the PIN1/NRF2/ARE Axis in Pancreatic Cancer

International Journal of Molecular Sciences

DOI

2023

Functional significance of cholesterol metabolism in cancer: from threat to treatment

Experimental and Molecular Medicine

DOI

2023

Mesenchymal Stromal Cell-Based Targeted Therapy Pancreatic Cancer: Progress and Challenges

International Journal of Molecular Sciences

DOI

2023

Integrated analysis revealed hypoxia signatures and LDHA related to tumor cell dedifferentiation and unfavorable prognosis in pancreatic adenocarcinoma

Translational Oncology

DOI

2023

Exosomes from TNF-α preconditioned human umbilical cord mesenchymal stromal cells inhibit the autophagy of acinar cells of severe acute pancreatitis via shuttling bioactive metabolites

Cellular and Molecular Life Sciences

DOI

2023

ASO Visual Abstract: Reappraisal of Tumor Deposit as a Prognostic Factor in Pancreatic Cancer

Annals of Surgical Oncology

DOI

2022

Signaling pathways in cancer‐associated fibroblasts: recent advances and future perspectives

Cancer Communications

DOI

2022

RNA N6-methyladenosine demethylase FTO promotes pancreatic cancer progression by inducing the autocrine activity of PDGFC in an m6A-YTHDF2-dependent manner

Oncogene

DOI

2022

Turning towards nonimmunoreactive tumors: Evaluation of cancer-associated fibroblasts enables prediction of the immune microenvironment and treatment sensitivity in pancreatic cancer

Computational and Structural Biotechnology Journal

DOI

2022

LDHA is a prognostic biomarker on the immune response in pancreatic adenocarcinoma and associated with m6A modification

Journal of Cancer Research and Clinical Oncology

DOI

2022

The Role of PDGFRA in Predicting Oncological and Immune Characteristics in Pancreatic Ductal Adenocarcinoma

Journal of Oncology

DOI

2022

Liquid–liquid phase separation in tumor biology

Signal Transduction and Targeted Therapy

DOI

2022

Turning up the heat on non-immunoreactive tumors: autophagy influences the immune microenvironment in pancreatic cancer

BMC Medical Genomics

DOI

2022

Pyroptosis-related lncRNA pairs to estimate the molecular features and prognostic outcomes of pancreatic ductal adenocarcinoma

Translational Oncology

DOI

2022

Comprehensive analysis of the prognosis and immune infiltration landscape of RNA methylation-related subtypes in pancreatic cancer

BMC Cancer

DOI

2022

Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research

Journal of Hematology & Oncology

DOI

2022

Construction of a paclitaxel-related competitive endogenous RNA network and identification of a potential regulatory axis in pancreatic cancer

Translational Oncology

DOI

2022

Intra-tumoral infiltration of adipocyte facilitates the activation of antitumor immune response in pancreatic ductal adenocarcinoma

Translational Oncology

DOI

2021

Applications of single-cell sequencing in cancer research: progress and perspectives

Journal of Hematology & Oncology

DOI

2021

Microorganisms in chemotherapy for pancreatic cancer: An overview of current research and future directions

International Journal on Biological Sciences

DOI

2021

A Novel Validated Recurrence Stratification System Based on 18F-FDG PET/CT Radiomics to Guide Surveillance After Resection of Pancreatic Cancer

Frontiers in Oncology

DOI

2021

Role of tumor mutation burden-related signatures in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma

Cancer Cell International

DOI

2021

Circular RNA CircEYA3 induces energy production to promote pancreatic ductal adenocarcinoma progression through the miR-1294/c-Myc axis

Molecular Cancer

DOI

2021

Analysis of Immune-Related Signatures Related to CD4+ T Cell Infiltration With Gene Co-Expression Network in Pancreatic Adenocarcinoma

Frontiers in Oncology

DOI

2021

Role of LRG1 in the Cell Proliferation, Migration, and Prognosis of Pancreatic Cancer

DOI

2021

Overcoming chemoresistance by targeting reprogrammed metabolism: the Achilles' heel of pancreatic ductal adenocarcinoma

Cellular and Molecular Life Sciences

DOI

2021

Development and multicenter validation of a nomogram for preoperative prediction of lymph node positivity in pancreatic cancer (NeoPangram).

Hepatobiliary & Pancreatic Diseases International

DOI

2021

From the Immune Profile to the Immunoscore: Signatures for Improving Postsurgical Prognostic Prediction of Pancreatic Neuroendocrine Tumors

Frontiers in Immunology

DOI

2021

Emerging roles of the solute carrier family in pancreatic cancer

Clinical and Translational Medicine

DOI

2021

Construction of a novel risk model based on the random forest algorithm to distinguish pancreatic cancers with different prognoses and immune microenvironment features

Bioengineered

DOI

2021

Head-to-head comparison between FOLFIRINOX and gemcitabine plus nab-paclitaxel in the neoadjuvant chemotherapy of localized pancreatic cancer: a systematic review and meta-analysis.

Gland surgery

DOI

2021

Circular RNA in pancreatic cancer: a novel avenue for the roles of diagnosis and treatment

Theranostics

DOI

2021

Ferroptosis-related lncRNA pairs to predict the clinical outcome and molecular characteristics of pancreatic ductal adenocarcinoma

Briefings Bioinform.

DOI

2021

Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives

Molecular Cancer

DOI

2021

Identification of the Roles of a Stemness Index Based on mRNA Expression in the Prognosis and Metabolic Reprograming of Pancreatic Ductal Adenocarcinoma

Frontiers in Oncology

DOI

2021

Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma

Frontiers in Immunology

DOI

2021

Ferroptosis: At the Crossroad of Gemcitabine Resistance and Tumorigenesis in Pancreatic Cancer

International Journal of Molecular Sciences

DOI

2021

Hyperdense Pancreatic Ductal Adenocarcinoma: Clinical Characteristics and Proteomic Landscape

Frontiers in Oncology

DOI

2020

Hypoxia: a barricade to conquer the pancreatic cancer

Cellular and Molecular Life Sciences

DOI

2020

Differentiation of solid-pseudopapillary tumors of the pancreas from pancreatic neuroendocrine tumors by using endoscopic ultrasound.

Clinics And Research in Hepatology and Gastroenterology

DOI

2020

Prognostic value of circulating tumor DNA in pancreatic cancer: a systematic review and meta-analysis

Aging

DOI

2020

The Strain Ratio as Obtained by Endoscopic Ultrasonography Elastography Correlates With the Stroma Proportion and the Prognosis of Local Pancreatic Cancer.

Annals of Surgery

DOI

2020

The promising role of noncoding RNAs in cancer-associated fibroblasts: an overview of current status and future perspectives

Journal of Hematology & Oncology

DOI

2020

A miR-146a-5p/TRAF6/NF-kB p65 axis regulates pancreatic cancer chemoresistance: functional validation and clinical significance

Theranostics

DOI

2020

Kras mutation correlating with circulating regulatory T cells predicts the prognosis of advanced pancreatic cancer patients

Cancer Medicine

DOI

2020

Comment on "Postoperative Chemotherapy Benefits Patients Who Received Preoperative Therapy and Pancreatectomy for Pancreatic Adenocarcinoma".

Annals of Surgery

DOI

2020

PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications

Molecular Cancer

DOI

2020

Ferroptosis, necroptosis, and pyroptosis in anticancer immunity

Journal of Hematology & Oncology

DOI

2020

The value of a metabolic reprogramming-related gene signature for pancreatic adenocarcinoma prognosis prediction

Aging

DOI

2020

The role of m6A-related genes in the prognosis and immune microenvironment of pancreatic adenocarcinoma

PeerJ

DOI

2020

Expression Patterns and Prognostic Value of DNA Damage Repair Proteins in Resected Pancreatic Neuroendocrine Neoplasms

Annals of Surgery

DOI

2020

The role of ferroptosis regulators in the prognosis, immune activity and gemcitabine resistance of pancreatic cancer

Annals of Translational Medicine

DOI

2020

TGFB1-induced autophagy affects the pattern of pancreatic cancer progression in distinct ways depending on SMAD4 status

Autophagy

DOI

2019

Validation and head-to-head comparison of four models for predicting malignancy of intraductal papillary mucinous neoplasm of the pancreas: A study based on endoscopic ultrasound findings

World Journal of Gastrointestinal Oncology

DOI

2019

Role of Damage DNA-Binding Protein 1 in Pancreatic Cancer Progression and Chemoresistance

Cancers

DOI

2019

KrasG12D mutation contributes to regulatory T cell conversion through activation of the MEK/ERK pathway in pancreatic cancer.

Cancer Letters

DOI

2019

Homeodomain‐interacting protein kinase 2 suppresses proliferation and aerobic glycolysis via ERK/cMyc axis in pancreatic cancer

Cell Proliferation

DOI

2019

The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications

Molecular Cancer

DOI

2019

A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma

Journal of Immunotherapy for Cancer

DOI

2019

Nab-paclitaxel plus gemcitabine as first-line treatment for advanced pancreatic cancer: a systematic review and meta-analysis

Journal of Cancer

DOI

2019

AJCC 7th edition staging classification is more applicable than AJCC 8th edition staging classification for invasive IPMN

World Journal of Surgical Oncology

DOI

2019

The microbiota and microbiome in pancreatic cancer: more influential than expected

Molecular Cancer

DOI

2019

Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer

Gut

DOI

2019

PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7/cMyc axis

Cell Communication and Signaling

DOI

2019

Proposed Modification of the 8th Edition of the AJCC Staging System for Pancreatic Ductal Adenocarcinoma

Annals of Surgery

DOI

2019

Prognostic value of lymph node positivity and number of lymph nodes required for accurate staging of pancreatic neuroendocrine tumors.

Journal of Clinical Oncology

DOI

2019

Determining the optimal number of examined lymph nodes for accurate staging of pancreatic cancer: An analysis using the nodal staging score model.

European Journal of Surgical Oncology

DOI

2019

Simultaneous resection of the primary tumour and liver metastases after conversion chemotherapy versus standard therapy in pancreatic cancer with liver oligometastasis: protocol of a multicentre, prospective, randomised phase III control trial (CSPAC-1)

BMJ Open

DOI

2019

Validation and head-to-head comparison of four models for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas: a study based on endoscopic ultrasound findings

Pancreatology (Print)

DOI

2018

TCF7L2 positively regulates aerobic glycolysis via the EGLN2/HIF-1α axis and indicates prognosis in pancreatic cancer

Cell Death and Disease

DOI

2018

Predictive value of the plasma D-dimer levels on stage and response to chemotherapy of the pancreatic cancer

DOI

2018

Abrogation of glutathione peroxidase-1 drives EMT and chemoresistance in pancreatic cancer by activating ROS-mediated Akt/GSK3β/Snail signaling

Oncogene

DOI

2018

GPx1 is involved in the induction of protective autophagy in pancreatic cancer cells in response to glucose deprivation

Cell Death and Disease

DOI

2018

Strategies for pancreatic anastomosis after pancreaticoduodenectomy: What really matters?

Hepatobiliary & Pancreatic Diseases International

DOI

2018

The impact of cancer-associated fibroblasts on major hallmarks of pancreatic cancer

Theranostics

DOI

2018

Zinc finger E-box-binding homeobox 1 mediates aerobic glycolysis via suppression of sirtuin 3 in pancreatic cancer

World Journal of Gastroenterology

DOI

2018

A novel scoring system predicts postsurgical survival and adjuvant chemotherapeutic benefits in patients with pancreatic adenocarcinoma: Implications for AJCC‐TNM staging

Surgery

DOI

2018

MiR‐29a, targeting caveolin 2 expression, is responsible for limitation of pancreatic cancer metastasis in patients with normal level of serum CA125

International Journal of Cancer

DOI

2018

Mismatch repair status as a beneficial predictor of fluorouracil‐based adjuvant chemotherapy for pancreatic cancer

Surgery

DOI

2018

PIN1 Maintains Redox Balance via the c-Myc/NRF2 Axis to Counteract Kras-Induced Mitochondrial Respiratory Injury in Pancreatic Cancer Cells.

Cancer Research

DOI

2018

New observations on the utility of CA19-9 as a biomarker in Lewis negative patients with pancreatic cancer.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

DOI

2018

Role of angiogenesis in pancreatic cancer biology and therapy.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

DOI

2018

Circulating biomarkers for early diagnosis of pancreatic cancer: facts and hopes.

American Journal of Cancer Research

2018

dCK negatively regulates the NRF2/ARE axis and ROS production in pancreatic cancer

Cell Proliferation

DOI

2018

Current status and dilemma of second-line treatment in advanced pancreatic cancer: is there a silver lining?

OncoTargets and Therapy

DOI

2017

Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19–9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma

Surgery

DOI

2017

Application value of Braun anastomosis in pancreaticoduodenectomy

DOI

2017

Do anti-stroma therapies improve extrinsic resistance to increase the efficacy of gemcitabine in pancreatic cancer?

Cellular and Molecular Life Sciences

DOI

2017

Surgery management for sporadic small (≤2 cm), non-functioning pancreatic neuroendocrine tumors: a consensus statement by the Chinese Study Group for Neuroendocrine Tumors (CSNET).

International Journal of Oncology

DOI

2017

A new facet of NDRG1 in pancreatic ductal adenocarcinoma: Suppression of glycolytic metabolism.

International Journal of Oncology

DOI

2017

Analysis of the advances in pancreatic cancer research from 2017 annual meeting of Chinese Society of Clinical Oncology

DOI

2017

Clinical outcomes and prognostic factors of resected pancreatic neuroendocrine neoplasms: A single-center experience in China.

Oncology Letters

DOI

2017

Modified Staging Classification for Pancreatic Neuroendocrine Tumors on the Basis of the American Joint Committee on Cancer and European Neuroendocrine Tumor Society Systems.

Journal of Clinical Oncology

DOI

2017

Analysis of ctDNA to predict prognosis and monitor treatment responses in metastatic pancreatic cancer patients

International Journal of Cancer

DOI

2017

Improved Survival in Patients with Resected Pancreatic Carcinoma Using Postoperative Intensity-Modulated Radiotherapy and Regional Intra-Arterial Infusion Chemotherapy

Medical Science Monitor

DOI

2017

Potential Biomarkers in Lewis Negative Patients With Pancreatic Cancer

Annals of Surgery

DOI

2017

Complex roles of the stroma in the intrinsic resistance to gemcitabine in pancreatic cancer: where we are and where we are going

Experimental and Molecular Medicine

DOI

2017

Prognostic Value of the CRP/Alb Ratio, a Novel Inflammation-Based Score in Pancreatic Cancer

Annals of Surgical Oncology

DOI

2017

Diagnostic Accuracy of a CA125-Based Biomarker Panel in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis

Journal of Cancer

DOI

2017

Revised nodal stage for pancreatic neuroendocrine tumors.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

DOI

2017

Carbohydrate antigen 19-9 as a prognostic biomarker in pancreatic neuroendocrine tumors.

Oncology Letters

DOI

2017

Patients with normal-range CA19-9 levels represent a distinct subgroup of pancreatic cancer patients.

Oncology Letters

DOI

2017

Neutrophil-lymphocyte ratio predicts survival in pancreatic neuroendocrine tumors.

Oncology Letters

DOI

2017

Diagnostic and prognostic value of carcinoembryonic antigen in pancreatic cancer: a systematic review and meta-analysis

OncoTargets and Therapy

DOI

2017

FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1

Oncology Report

DOI

2017

ARF6, induced by mutant Kras, promotes proliferation and Warburg effect in pancreatic cancer.

Cancer Letters

DOI

2017

Distribution of Lewis and Secretor polymorphisms and corresponding CA19‐9 antigen expression in a Chinese population

FEBS Open Bio

DOI

2017

Somatic Genetic Variation in Solid Pseudopapillary Tumor of the Pancreas by Whole Exome Sequencing

International Journal of Molecular Sciences

DOI

2016

某县5岁以下儿童死亡率变化趋势

《中国卫生统计》

2016

CDKN2A/p16 modulates the levels of various microRNAs in pancreatic cancer

DOI

2016

The Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer

International Journal of Molecular Sciences

DOI

2016

Critical role of oncogenic KRAS in pancreatic cancer (Review).

Molecular Medicine Reports

DOI

2016

Surgical management for non-functional pancreatic neuroendocrine neoplasms with synchronous liver metastasis: A consensus from the Chinese Study Group for Neuroendocrine Tumors (CSNET).

International Journal of Oncology

DOI

2016

Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients with preoperative serum CA19-9 ≥ 1,000 U/mL

Scientific Reports

DOI

2016

Metabolic plasticity in heterogeneous pancreatic ductal adenocarcinoma.

Biochimica et Biophysica Acta

DOI

2016

The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patients.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

DOI

2016

Roux-en-Y pancreaticojejunostomy reconstruction after deep enucleation of benign or borderline pancreatic lesions: a single-institution experience.

HPB

DOI

2016

Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden

OncoTarget

DOI

2016

Optimize CA19-9 in detecting pancreatic cancer by Lewis and Secretor genotyping.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

DOI

2016

New insights into perineural invasion of pancreatic cancer: More than pain.

Biochimica et Biophysica Acta

DOI

2016

Oncogenic KRAS Targets MUC16/CA125 in Pancreatic Ductal Adenocarcinoma

Molecular Cancer Research

DOI

2016

Retraction: Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients with preoperative serum CA19-9 ≥ 1,000 U/mL

Scientific Reports

DOI

2016

ALDOA functions as an oncogene in the highly metastatic pancreatic cancer.

Cancer Letters

DOI

2016

Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma

British Journal of Surgery

DOI

2016

FBW7 (F-box and WD Repeat Domain-Containing 7) Negatively Regulates Glucose Metabolism by Targeting the c-Myc/TXNIP (Thioredoxin-Binding Protein) Axis in Pancreatic Cancer

Clinical Cancer Research

DOI

2016

Which patients with para-aortic lymph node (LN16) metastasis will truly benefit from curative pancreaticoduodenectomy for pancreatic head cancer?

OncoTarget

DOI

2016

Energy sources identify metabolic phenotypes in pancreatic cancer.

Acta Biochimica et Biophysica Sinica

DOI

2016

VEGF Promotes Glycolysis in Pancreatic Cancer via HIF1α Up-Regulation.

Current molecular medicine

DOI

2016

MBD1 is an Epigenetic Regulator of KEAP1 in Pancreatic Cancer.

Current molecular medicine

DOI

2015

浙江省青田县母婴健康工程项目效果分析

《上海预防医学》

2015

FBP1, A tumor suppressor and negative regulator of glycolysis, was epigenetically silenced in pancreatic cancer

DOI

2015

Noncoding RNAs as potential biomarkers to predict the outcome in pancreatic cancer

Drug Design, Development and Therapy

DOI

2015

A comprehensive comparison of clinicopathologic and imaging features of incidental/symptomatic non-functioning pancreatic neuroendocrine tumors: A retrospective study of a single center.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

DOI

2015

High Expression of Human Leukocyte Antigen-G is Associated with a Poor Prognosis in Patients with PDAC.

Current molecular medicine

DOI

2015

A preoperative serum signature of CEA+/CA125+/CA19‐9 ≥ 1000 U/mL indicates poor outcome to pancreatectomy for pancreatic cancer

International Journal of Cancer

DOI

2015

Intensity modulated radiotherapy for locally advanced and metastatic pancreatic cancer: a mono-institutional retrospective analysis

Radiation Oncology

DOI

2015

Papillary-like main pancreatic duct invaginated pancreaticojejunostomy versus duct-to-mucosa pancreaticojejunostomy after pancreaticoduodenectomy: A prospective randomized trial.

Surgery

DOI

2015

Metabolic tumor burden: a new promising way to reach precise personalized therapy in PDAC.

Cancer Letters

DOI

2015

Metabolic tumor burden is associated with major oncogenomic alterations and serum tumor markers in patients with resected pancreatic cancer.

Cancer Letters

DOI

2015

Epithelial-mesenchymal transition in pancreatic cancer: Is it a clinically significant factor?

Biochimica et Biophysica Acta

DOI

2015

Lymph node status predicts the benefit of adjuvant chemoradiotherapy for patients with resected pancreatic cancer.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

DOI

2015

ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer

Cell Research

DOI

2014

LSD1 sustains pancreatic cancer growth via maintaining HIF1α-dependent glycolytic process.

Cancer Letters

DOI

2014

(18)F-FDG PET/CT can be used to detect non-functioning pancreatic neuroendocrine tumors.

International Journal of Oncology

DOI

2014

Abnormal distribution of peripheral lymphocyte subsets induced by PDAC modulates overall survival.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

DOI

2014

Cavin-1 is essential for the tumor-promoting effect of caveolin-1 and enhances its prognostic potency in pancreatic cancer

Oncogene

DOI

2014

Blood Neutrophil–Lymphocyte Ratio Predicts Survival in Patients with Advanced Pancreatic Cancer Treated with Chemotherapy

Annals of Surgical Oncology

DOI

2014

Stathmin, interacting with Nf-κB, promotes tumor growth and predicts poor prognosis of pancreatic cancer.

Current molecular medicine

DOI

2014

Metabolic tumour burden assessed by 18F-FDG PET/CT associated with serum CA19-9 predicts pancreatic cancer outcome after resection

European Journal of Nuclear Medicine and Molecular Imaging

DOI

2014

Cancer statistics: current diagnosis and treatment of pancreatic cancer in Shanghai, China.

Cancer Letters

DOI

2014

miR-1247 is correlated with prognosis of pancreatic cancer and inhibits cell proliferation by targeting neuropilins.

Current molecular medicine

DOI

2014

Profilin-1 suppresses tumorigenicity in pancreatic cancer through regulation of the SIRT3-HIF1α axis

Molecular Cancer

DOI

2014

Effect of the number of positive lymph nodes and lymph node ratio on prognosis of patients after resection of pancreatic adenocarcinoma.

Hepatobiliary & Pancreatic Diseases International

DOI

2014

Study of the relationship between sphenoid sinus volume and protrusions in the sphenoid sinus

Forensic Medicine and Anatomy Research

DOI

2013

Highly lymphatic metastatic pancreatic cancer cells possess stem cell-like properties.

International Journal of Oncology

DOI

2013

Intratumoral α-SMA Enhances the Prognostic Potency of CD34 Associated with Maintenance of Microvessel Integrity in Hepatocellular Carcinoma and Pancreatic Cancer

PLoS ONE

DOI

2013

Silencing of MBD1 reverses pancreatic cancer therapy resistance through inhibition of DNA damage repair.

International Journal of Oncology

DOI

2013

Ligamentum teres hepatis patch enhances the healing of pancreatic fistula after distal pancreatectomy.

Hepatobiliary & Pancreatic Diseases International

DOI

2013

CA125 is Superior to CA19-9 in Predicting the Resectability of Pancreatic Cancer

Journal of Gastrointestinal Surgery

DOI

2013

Profilin 1 potentiates apoptosis induced by staurosporine in cancer cells.

Current molecular medicine

DOI

2013

Up-regulation of MBD1 promotes pancreatic cancer cell epithelial-mesenchymal transition and invasion by epigenetic down-regulation of E-cadherin.

Current molecular medicine

DOI

2013

Application of “Papillary-Like Main Pancreatic Duct Invaginated” Pancreaticojejunostomy for Normal Soft Pancreas Cases

Scientific Reports

DOI

2012

贫困高危孕产妇抢救基金会对降低孕产妇死亡率的作用

《上海预防医学》

2012

RGD-conjugated albumin nanoparticles as a novel delivery vehicle in pancreatic cancer therapy

Cancer Biology & Therapy

DOI

2012

胰腺癌患者外周血CD8＋CD28＋和CD8＋CD28-T淋巴细胞亚群的分析

2012

CD8+ T Cells Are Compromised In Human Pancreatic Cancer

DOI

2012

microRNA signature for human pancreatic cancer invasion and metastasis.

Experimental and Therapeutic Medicine

DOI

2012

The role of preoperative CA19-9 level in predicting resectability of pancreatic cancer

DOI

2012

Pancreatic stump-closed pancreaticojejunostomy can be performed safely in normal soft pancreas cases.

Journal of Surgical Research

DOI

2012

Management of a malignant case of solid pseudopapillary tumor of pancreas: a case report and literature review.

Pancreas

DOI

2012

Combinational therapy: new hope for pancreatic cancer?

Cancer Letters

DOI

2012

Quantum dots in cancer therapy

Expert Opinion on Drug Delivery

DOI

2012

Stroma and pancreatic ductal adenocarcinoma: an interaction loop.

Biochimica et Biophysica Acta

DOI

2012

Development of a unique mouse model for pancreatic cancer lymphatic metastasis.

International Journal of Oncology

DOI

2011

近5年我国大学新生心理健康元分析

《中国学校卫生》

2011

Role of Epidermal Growth Factor Receptor Expression on Patient Survival in Pancreatic Cancer: A Meta-Analysis

Pancreatology (Print)

DOI

2011

CD24^＋CD44^＋胰腺癌细胞的获取及其干细胞特性的初步鉴定

2011

人工乳头植入式胰-空肠吻合的初步应用（附10例临床应用体会）

2010

Pancreatic cancer: gene therapy approaches and gene delivery systems

Expert Opinion on Biological Therapy

DOI

2010

Developmental plasticity of stem cells and diseases.

Medical Hypotheses

DOI

2010

Carbon nanotubes in cancer diagnosis and therapy.

Biochimica et Biophysica Acta

DOI

2010

残端封闭型内置管嵌入式胰-空肠吻合法在胰十二指肠切除术中的应用（附21例分析）

2009

MBD1 RNA干扰对胰腺癌细胞VIMENTIN、GRP78表达影响的实验研究

2009

MBD1 RNA干扰对胰腺癌细胞株BxPC-3生长影响的实验研究

2009

RNA interference of MBD1 in BxPC-3 human pancreatic cancer cells delivered by PLGA-poloxamer nanoparticles

Cancer Biology & Therapy

DOI

2009

Detection of lymph node micrometastasis in pancreatic head carcinoma

DOI

2009

Pancreatic adenocarcinoma: dynamic 64-slice helical CT with perfusion imaging

Abdominal Imaging

DOI

2009

胰腺癌多药耐药细胞株BxPC～3／ADM的建立及耐药机制的初步探讨

2009

Effect of multiple‐phase regional intra‐arterial infusion chemotherapy on patients with resectable pancreatic head adenocarcinoma

Chinese Medical Journal

DOI

2009

Construction of multidrug resistant cell line BxPC-3/ADM of pancreatic cancer and initial investigation of its resistance mechanism

DOI

2009

Solid pseudopapillary tumor of the pancreas: a case series of 26 consecutive patients.

American Journal of Surgery

DOI

2009

MDR1 siRNA对胰腺癌细胞株BxPC-3耐药性影响的实验研究

2008

[Activation of multiple tumor suppressor genes by MBD1 siRNA in pancreatic cancer cell line BxPC-3].

Zhonghua yi xue za zhi

DOI

2008

Proteomic analysis of differential proteins in pancreatic carcinomas: Effects of MBD1 knock-down by stable RNA interference

BMC Cancer

DOI

2008

Aberrant Hepatic Artery in Patients Undergoing Pancreaticoduodenectomy

Pancreatology (Print)

DOI

2008

Clinical features of hepatic arterial variation found during pancreatoduodenectomy

DOI

2008

Clinical experiences of solid pseudopapillary tumors of the pancreas in China

Journal of Gastroenterology and Hepatology

DOI

2007

Bacteriological study and risk factors of intra-abdominal infection after pancreaticoduodenectomy

2007

胰腺癌bcl-xL、cyclin D1的表达及其与STAT3的相互关系

2007

Primary intestinal malignant fibrous histiocytoma: two case reports.

World Journal of Gastroenterology

DOI

2004

青田县农村防保体制改革探索

《预防医学》

2002

加贝酯对急性胆囊炎临床疗效观察

DOI

2002

加贝酯对金黄地鼠胆囊及Oddi括约肌收缩的影响

DOI

2001

胰腺癌免疫治疗的进展(文献综述)

DOI